Abstract | BACKGROUND: The objective of this study is to examine the overall clinical results of endoscopic injection sclerotherapy (EIS) for patients with esophageal varices in our institution. METHODS: From January 1982 to May 2001, 2105 patients with esophageal varices were treated with EIS, which included prophylactic injections for patients with risky varices according to our criteria. Follow-up endoscopy was performed every 3 months, and recurrent varices were treated with additional EIS. RESULTS: Acute variceal bleeding was controlled in 468 of 473 patients (98.9%). Esophageal varices were completely eradicated in 1757 of 2105 patients (83.5%) with 3.8 +/- 1.6 sessions of EIS. The cumulative recurrence rates were 32.2% at 5 years, 36.5% at 10 years, and 37.8% at 15 years. The cumulative nonbleeding rates were 92.3% at 5 years, 90.1% at 10 years, and 89.5% at 15 years. The survival rate of acute bleeders was significantly lower than for both elective and prophylactic cases (P <.05). The overall cumulative survival rate was 28.2% at 10 years. CONCLUSIONS: EIS is the first choice of treatment for esophageal variceal bleeding, and rebleeding was shown to be well controlled in a long-term follow-up with endoscopy and additional EIS. The lower survival rate observed in acute bleeders may therefore justify the use of prophylactic EIS.
|
Authors | Morimasa Tomikawa, Makoto Hashizume, Keishi Okita, Seigo Kitano, Masayuki Ohta, Hidefumi Higashi, Tomohiko Akahoshi |
Journal | Surgery
(Surgery)
Vol. 131
Issue 1 Suppl
Pg. S171-5
(Jan 2002)
ISSN: 0039-6060 [Print] United States |
PMID | 11821806
(Publication Type: Clinical Trial, Journal Article)
|
Topics |
- Acute Disease
- Aged
- Endoscopy, Gastrointestinal
- Esophageal and Gastric Varices
(mortality, therapy)
- Female
- Follow-Up Studies
- Gastrointestinal Hemorrhage
(mortality, therapy)
- Humans
- Male
- Middle Aged
- Recurrence
- Sclerotherapy
- Survival Rate
- Treatment Outcome
|